Roche has shared long-term phase 2 data on its BTK inhibitor fenebrutinib in relapsing multiple sclerosis (MS), providing evidence of durability over 96 weeks to build out its case ahead of the ...

FRANKFURT — Swiss drugmaker Roche (ROG.S), said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious hospital infections into the ...

Roche Diagnostics will invest $550 million in its Indianapolis base to construct a new manufacturing facility for glucose monitoring devices, which will add several hundred jobs and further ...

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in ...

INDIANAPOLIS, May 12, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today it plans to invest up to $550 million in its Diagnostics site in Indianapolis by 2030. The site will ...

George Thomas Roche, age 92, passed away on Sunday, May 18, 2025, surrounded by family and friends in Berlin, Maryland. Born in Waltham, MA, he was the son of the late James Patrick Roche and ...

Even as Roche makes a major investment pledge across its U.S. business, the Swiss pharmaceutical giant isn’t neglecting its chief markets in Asia. Roche is investing roughly 2.04 billion Chinese ...

Edward Charles “Ed” Roche, aged 92 of Brockton, passed away on May 26, 2025 after a brief illness. He was born in Boston on April 28, 1933, the youngest of five children to Mary (Muise ...

Roche Bermuda has awarded three $10,000 scholarships to graduating students at Bermuda College. A spokesperson said, “This historic contribution comes as Roche Bermuda celebrates its 30-year ...

Roche’s Herceptin and Perjeta duo is already part of a well-established standard of care in early-stage HER2-positive breast cancer. Now, the company can further back up the regimen’s prowess ...